Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-30 Sale | 2025-05-01 7:07 pm | Acrivon Therapeutics Inc. | ACRV | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 736,767 | $1.3816 | $1,017,919 | 3,104,139 (Indirect) | View |
| 2025-04-25 Sale | 2025-04-29 7:26 pm | Acrivon Therapeutics Inc. | ACRV | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 1,519,952 | $1.8059 | $2,744,946 | 3,840,906 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-11-21 Tax Withholding | 2025-11-25 4:03 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 19,904 | $2.3 | 2,361,477 (Direct) | View |
| 2025-11-14 Tax Withholding | 2025-11-18 4:33 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $2.24 | 4,122 (Direct) | View |
| 2025-11-14 Tax Withholding | 2025-11-18 4:32 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $2.24 | 34,555 (Direct) | View |
| 2025-11-14 Tax Withholding | 2025-11-18 4:30 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 403 | $2.24 | 15,283 (Direct) | View |
| 2025-11-14 Tax Withholding | 2025-11-18 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $2.24 | 65,308 (Direct) | View |
| 2025-11-14 Tax Withholding | 2025-11-18 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 60,255 | $2.24 | 2,381,381 (Direct) | View |
| 2025-10-17 Tax Withholding | 2025-10-21 4:06 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $1.81 | 34,739 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 4:28 pm | N/A 2035-09-30 | Acrivon Therapeutics Inc. | ACRV | Mirza Mansoor Raza Chief Medical Officer | 225,000 | $0 | 225,000 (Direct) | View |
| 2025-10-01 Tax Withholding | 2025-10-03 4:26 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 284 | $1.81 | 35,297 (Direct) | View |
| 2025-08-21 Tax Withholding | 2025-08-25 4:39 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 19,905 | $1.32 | 2,441,636 (Direct) | View |
| 2025-08-14 Tax Withholding | 2025-08-18 5:19 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $1.39 | 4,221 (Direct) | View |
| 2025-08-14 Tax Withholding | 2025-08-18 5:18 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $1.39 | 35,581 (Direct) | View |
| 2025-08-14 Tax Withholding | 2025-08-18 5:16 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 403 | $1.39 | 15,686 (Direct) | View |
| 2025-08-14 Tax Withholding | 2025-08-18 5:15 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $1.39 | 65,921 (Direct) | View |
| 2025-08-14 Tax Withholding | 2025-08-18 5:14 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 60,256 | $1.39 | 2,461,541 (Direct) | View |
| 2025-08-01 Tax Withholding | 2025-08-05 4:59 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 1,164 | $1.26 | 12,151 (Direct) | View |
| 2025-07-17 Tax Withholding | 2025-07-21 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $1.32 | 35,765 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-17 8:17 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 20,275 | $0 | 20,275 (Indirect) | View |
| 2025-06-13 Option Award | 2025-06-17 6:04 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | DiRocco Derek Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-17 5:57 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-17 5:54 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-17 5:49 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | Palani Santhosh Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-17 5:48 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | Magovcevic-Liebisch Ivana Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-17 5:21 pm | N/A 2035-06-12 | Acrivon Therapeutics Inc. | ACRV | BAUM CHARLES M Director | 20,275 | $0 | 20,275 (Direct) | View |
| 2025-05-21 Tax Withholding | 2025-05-23 4:58 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 19,904 | $1.15 | 2,521,797 (Direct) | View |
| 2025-05-14 Tax Withholding | 2025-05-16 4:21 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 99 | $1.14 | 4,320 (Direct) | View |
| 2025-05-14 Tax Withholding | 2025-05-16 4:20 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 184 | $1.14 | 36,323 (Direct) | View |
| 2025-05-14 Tax Withholding | 2025-05-16 4:18 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 403 | $1.14 | 16,089 (Direct) | View |
| 2025-05-14 Tax Withholding | 2025-05-16 4:17 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer | 613 | $1.14 | 66,534 (Direct) | View |
| 2025-05-14 Tax Withholding | 2025-05-16 4:16 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter Masson Kristina President and CEO | 60,257 | $1.14 | 2,541,701 (Direct) | View |
| 2025-04-17 Tax Withholding | 2025-04-18 3:51 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 558 | $1.81 | 36,507 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:32 pm | N/A 2035-03-31 | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 15,616 | $0 | 15,616 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 4:30 pm | N/A 2035-03-31 | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 35,209 | $0 | 35,209 (Direct) | View |
Ownership | 2025-04-03 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Levy Adam D. Chief Financial Officer | 0 | $0 | 169,340 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 5:36 pm | N/A 2035-02-28 | Acrivon Therapeutics Inc. | ACRV | Peterson Katharine Chief Accounting Officer | 31,900 | $0 | 31,900 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 5:31 pm | N/A 2035-02-28 | Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer | 93,693 | $0 | 93,693 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 5:28 pm | N/A 2035-02-28 | Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer | 109,309 | $0 | 109,309 (Direct) | View |